OARSI-FDA initiative: Defining the disease state of osteoarthritis, Osteoarthr. Cartil, vol.19, pp.478-482, 2011. ,
Prevalence of Doctor-Diagnosed Arthritis at State and County Levels-United States, MMWR Morb. Mortal. Wkly. Rep, vol.65, pp.489-494, 2014. ,
Weight loss reduces the risk for symptomatic knee osteoarthritis in woman. The Framingham Study, Ann. Intern. Med, vol.116, pp.535-539, 1992. ,
Intraarticular corticosteroid for treatment of osteoarthritis of the knee, Cochrane Database Syst. Rev, vol.19, p.5328, 2006. ,
The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: A systematic review of level I studies, J. Am. Acad. Orthop. Surg, vol.17, pp.638-646, 2009. ,
Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: A systematic review and meta-analysis, Arthritis Rheum, vol.61, pp.1704-1711, 2009. ,
Association of Pharmacological Treatments with Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis, JAMA, vol.320, pp.2564-2579, 2018. ,
AAOS clinical practice guidelines. Treatment of osteoarthritis of the knee: Evidence-based guideline, 2ded, J. Am. Acad. Orthop. Surg, vol.21, pp.577-579, 2013. ,
Platelet-rich plasma (PRP): What is PRP and what is not PRP? Implant Dent, vol.10, pp.225-228, 2001. ,
Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials, vol.33, pp.659-670, 2017. ,
Editorial Commentary: The Time Has Come to Try Intra-articular Platelet-Rich Plasma Injections for Your Patients with Symptomatic Knee Osteoarthritis, vol.33, pp.671-672, 2017. ,
Characterization and comparison of 5 Platelet-Rich Plasma preparations in a single donor model, Arthroscopy, vol.30, pp.629-638, 2014. ,
Comparion of growth factor and platelet concentration from commercial platelet-rich plasma separation systems, Am. J. Sports Med, pp.39-266, 2011. ,
Effect of leukocyte concentration on the efficacy of Platelet rich Plasma in the treatment of knee osteoarthritis, Am. J. Sports Med, vol.44, pp.792-800, 2016. ,
Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis, Arch. Orthop. Trauma Surg, vol.136, pp.1723-1732, 2016. ,
Optimizing Clinical Use of Biologics in Orthopaedic Surgery: Consensus Recommendations from the 2018 AAOS/NIH U-13 Conference, J. Am. Acad. Orthop. Surg, vol.27, pp.50-63, 2019. ,
DEPA classification: A proposal for standardising PRP use and a retrospective application of available devices, BMJ Open Sport Exerc. Med, 2016. ,
Fundamentals of Joint Injection, Am. J. Roentgenol, vol.207, pp.484-494, 2016. ,
Growth Factors Levels Determine Efficacy of Platelets Rich Plasma Injection in Knee Osteoarthritis: A Randomized Double Blind Noninferiority Trial Compared with Viscosupplementation, Arthroscopy, vol.34, pp.1530-1540, 2018. ,
Clinical and radiographic comparison of a single LP-PRP injection, a single hyaluronic acid injection and daily NSAID administration with a 52-week follow-up: A randomized controlled trial, J. Orthop. Traumatol, vol.19, 2018. ,
Treatment of knee osteoarthritis: Platelet-derived growth factors vs. hyaluronic acid. A randomized controlled trial, Clin. Rehabil, vol.32, pp.330-339, 2018. ,
Patellar articular cartilage lesions: in vitro MR imaging evaluation after placement in gadopentetate dimeglumine solution, Radiology, vol.230, pp.768-773, 2004. ,
The placebo effect and its determinants in osteoarthritis: Meta-analysis of randomised controlled trials, Ann. Rheum Dis, vol.67, pp.1716-1723, 2008. ,
Use of platelet-rich plasma in regenerative medicine: Technical tools for correct quality control, BMJ Open Sport Exerc. Med, vol.13, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02060871